And the timeframes are very impressive - based on the timeframes that the Japanese PMDA approved Remdesivir we could be approved there in 4 days and then 3 business days is the Indian mandate for approval - so MSB could be treating patients in India in a week.
Wouldn't it be great if MSB put out a release saying they were at least pursuing this option?
I mentioned that Japan is entering their 4th wave and it's looking like it's going to be their worst plus they've only vaccinated 2% of their population.
https://www.japantimes.co.jp/news/2021/05/03/national/coronavirus-japan-may3/
And the timeframes are very impressive - based on the timeframes...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.58 |
Change
0.005(0.32%) |
Mkt cap ! $1.798B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.61 | $1.52 | $6.446M | 4.092M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 62215 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 14678 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |